Medical costs, hospitalizations, and length of stay associated with discontinuations in cycled oral antineoplastics among Medicare-eligible oncology patients

Summary

MarketScan Medicare study sample demonstrated that medication adherence (fewer gaps in medicaton coverage) among patients on cycled oral antineoplastics can lead to lower medical costs, fewer hospitlization events and shorter lenght of stay as compared to lower adherence levels.

DATE PUBLISHED

May 07, 2023

FORMAT

Poster

AUTHORS

Francis Staskon, Edward A. Witt, Laly Havern